Gamma-secretase inhibitor IX (GSI) was confirmed to effectively inhibit the proliferation, migration and invasiveness of GC cells and induce apoptosis of GC cells by targeting CD44+ GCSCs. This evidence concerns the gene CD44 and gastric cancer.